论文部分内容阅读
Objective To explore the efficacies and adverse events of sorafenib in the treatment of advanced metastatic renal cell carcinoma.Methods A total of 57 patients with advanced kidney cancer were recruited from our hospital from April 2007 to October 2011.They were divided into sorafenib group (A,n=24) and sorafenib+
Objective To explore the efficacies and adverse events of sorafenib in the treatment of advanced metastatic renal cell carcinoma. Methods A total of 57 patients with advanced kidney cancer were recruited from our hospital from April 2007 to October 2011. They were divided into sorafenib group (A , n = 24) and sorafenib +